UIS2

UIS2 (PF3D7_1464600) is a PP2C/PPM-family serine/threonine protein phosphatase that controls Plasmodium translational status by dephosphorylating eukaryotic initiation factor 2α at phosphoserine-59, the eIF2α-P that suppresses translation (PMID:26735921). Conditional knockout in sporozoites causes accumulation of eIF2α-P and loss of infectivity, establishing UIS2 as the eIF2α-P phosphatase required for the sporozoite-to-liver-stage transition—a role played by PP1 in mammalian cells but delegated to this PP2C-family enzyme in the parasite (PMID:26735921). UIS2 forms an unusually stable phosphatase–substrate complex with phosphorylated eIF2α rather than the transient association typical of eukaryotic phosphatases (PMID:26735921), and its activity is gated developmentally: the Pumilio protein Puf2 translationally represses UIS2 in salivary-gland sporozoites, with de-repression on liver-stage entry permitting eIF2α-P dephosphorylation and resumption of translation (PMID:26735921, PMID:28357358). In blood-stage parasites UIS2 localises to the parasitophorous vacuole/PV membrane rather than the cytoplasm and appears essential for growth (PMID:28784333), with the P. berghei orthologue independently identified as a PV membrane protein (PMID:29404413). UIS2 carries a bona fide PEXEL motif cleaved by Plasmepsin V, but an atypical aspartate at the P1' position (RIL↓DE) permits cleavage while blocking export, so that mature N-terminal residue identity—not PEXEL processing itself—dictates its non-exported fate (PMID:38334391).

1. 2008 Low

   Before any function was known, UIS2 needed to be placed within the parasite enzyme repertoire to predict its catalytic class.

   Evidence Bioinformatic phosphatome analysis of P. falciparum (PlasmoDB mining, phylogenetics)

   PMID:18793411

   Open questions at the time

   • Purely computational classification with no biochemical validation
   • Does not distinguish UIS2 from the six other closely related PP2C/PPM members
   • No substrate or cellular role implied
2. 2016 High

   The central question of what UIS2 does was answered by identifying eIF2α-P as its substrate and showing it is required for the sporozoite-to-liver-stage transition, defining a PP2C-based route to translational recovery distinct from the mammalian PP1 system.

   Evidence Conditional knockout parasites, eIF2α phosphorylation measurement, sporozoite infectivity assays, plus a stable-binding co-IP with eIF2α-P

   PMID:26735921

   Open questions at the time

   • Stable phosphatase–substrate binding shown but not resolved to the residue level at this stage
   • Catalytic residues/mechanism not defined biochemically
   • Substrate specificity beyond eIF2α not tested
3. 2016 Medium

   How UIS2 activity is timed across the life cycle was addressed by showing Puf2 translationally represses UIS2 in dormant sporozoites and releases it upon liver-stage entry.

   Evidence Genetic analysis of uis2 expression in wild-type versus puf2 mutant sporozoites and liver stages

   PMID:26735921 PMID:28357358

   Open questions at the time

   • Direct binding of Puf2 to uis2 mRNA not detailed here
   • Other regulators of UIS2 timing not excluded
   • Single-lab expression analysis
4. 2017 Medium

   The assumed cytoplasmic site of UIS2 action was overturned by localising it to the parasitophorous vacuole in blood-stage parasites and inferring essentiality from failed disruption.

   Evidence BioID proximity biotinylation, GFP knock-in localisation, and unsuccessful targeted gene disruption in P. falciparum

   PMID:28784333

   Open questions at the time

   • Essentiality inferred from failure to disrupt rather than conditional depletion
   • How a PV-localised phosphatase reaches cytoplasmic eIF2α is unresolved
   • Reconciliation with the eIF2α-P role not established
5. 2018 Medium

   The PV localisation was corroborated in a second species by identifying the P. berghei orthologue as a PV membrane protein across blood and liver stages.

   Evidence BioID with a BirA*-EXP1 PVM marker, affinity purification, LC-MS/MS, and localisation validation in P. berghei

   PMID:29404413

   Open questions at the time

   • Functional consequences of PVM residence not tested in P. berghei
   • Membrane topology not defined
   • Link to eIF2α dephosphorylation not addressed in this system
6. 2024 High

   The trafficking logic was clarified by showing UIS2 has a PEXEL motif cleaved by Plasmepsin V yet is not exported, because an atypical P1' aspartate permits cleavage while blocking export.

   Evidence Chimeric reporter fusions, Plasmepsin V cleavage assays, and P1' Asp-to-Ala mutagenesis with export assays in P. falciparum blood stages

   PMID:38334391

   Open questions at the time

   • Physiological role of PEXEL processing for UIS2 function not established
   • How the cleaved N-terminus relates to PV/PVM targeting not defined
   • Does not address the eIF2α catalytic mechanism
7. 2025 Low

   A structural rationale for parasite-selective eIF2α-P recognition was modelled, proposing dual-domain engagement of the phosphoserine-59 loop and a six-patch electrostatic pocket exploited by the inhibitor Salubrinal.

   Evidence AlphaFold modelling, molecular dynamics/metadynamics, docking, and free-energy perturbation (preprint)

   PMID:40463039

   Open questions at the time

   • Entirely computational with no in vitro or mutagenesis validation
   • Proposed binding patches not experimentally confirmed
   • Salubrinal selectivity not tested against parasites

• It remains unresolved how a PV/PVM-localised phosphatase physically accesses and dephosphorylates cytoplasmic eIF2α, and whether UIS2 has substrates beyond eIF2α.
• Topological reconciliation of PV localisation with cytoplasmic substrate
• No experimentally validated active-site or catalytic mechanism
• Substrate repertoire beyond eIF2α unknown